18-Fluorodeoxyglucose positron emission tomography/computed tomography for large vessel vasculitis in clinical practice

Diagnosis, prognostic assessment, and monitoring disease activity in patients with large vessel vasculitis (LVV) can be challenging. Early recognition of LVV and treatment adaptation is essential because vascular complications (aneurysm, dilatations, ischemic complications) or treatment related side...

Descripción completa

Detalles Bibliográficos
Autores principales: Nassarmadji, Kladoum, Vanjak, Anthony, Bourdin, Venceslas, Champion, Karine, Burlacu, Ruxandra, Mouly, Stéphane, Sène, Damien, Comarmond, Cloé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892645/
https://www.ncbi.nlm.nih.gov/pubmed/36744139
http://dx.doi.org/10.3389/fmed.2023.1103752
Descripción
Sumario:Diagnosis, prognostic assessment, and monitoring disease activity in patients with large vessel vasculitis (LVV) can be challenging. Early recognition of LVV and treatment adaptation is essential because vascular complications (aneurysm, dilatations, ischemic complications) or treatment related side effects can occur frequently in these patients. 18-fluorodeoxyglucose positron emission tomography/computed tomography (2-[18F]FDG-PET/CT) is increasingly used to diagnose, follow, and evaluate treatment response in LVV. In this review, we aimed to summarize the current evidence on the value of 2-[18F]FDG-PET/CT for diagnosis, follow, and treatment monitoring in LVV.

Ejemplares similares